[1]
S. Nazir, “A Hemodynamic Study to assess response, tolerance and dose optimization of Carvedilol in Child Class A patients with Portal Hypertension”, Asian J Med Sci, vol. 12, no. 8, pp. 34–40, Jul. 2021.